Glioblastoma (GBM), the most aggressive WHO grade 4 brain tumor, has a median survival of ~15 months and a five-year survival rate of only 7%. The current surgical and chemotherapeutic approaches remain insufficient for its treatment. A major obstacle in its treatment is the presence of hostile tumor microenvironment (...
Cancer is one of the leading global health crises in the 21st century, accounting for nearly one in six deaths worldwide. Conventional treatment modalities, including surgery, chemotherapy, radiotherapy, and immunotherapy, remain insufficient and are frequently sabotaged due to the tumor complexity. Parallelly, there...